VAERS reports by lot

Merck HPV lot M004116: VAERS reports

59 VAERS reports list lot M004116 as a Merck HPV vaccine, received between 2016-05-12 and 2017-10-30. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
59
Reports
15%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological2326%
Gastrointestinal2022%
General / Systemic (non-local)2022%
Cardiac / Cardiovascular1011%
Allergic / Anaphylactic44%
Musculoskeletal44%
Injection-site / Local reaction44%
Dermatological (non-injection-site)33%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas7
Virginia4
New York3
Ohio3
Pennsylvania3
Michigan3
Georgia3
Maryland2
Maine1
Puerto Rico1
North Carolina1
New Jersey1

Reports by month received

2016-055
2016-066
2016-0714
2016-0813
2016-095
2016-104
2016-113
2016-122
2017-021
2017-031
2017-051
2017-061
2017-081
2017-102

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.